FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Deres

Research Profile

Living Beings

Physiology

Phenomena

Phosphorylation

Chemicals & Drugs

Disorders

Reperfusion Injury

Co-author Network

Publications

TOP 3
Anita Palfi; Ambrus Toth; Katalin Hanto; Peter Deres; Eszter Szabados; Zoltan Szereday; Gyozo Kulcsar; Tamas Kalai; Kálmán Hideg; Ferenc Gallyas Jr; Balazs Sumegi; Kalman Toth; Robert Halmosi
PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
Krisztina Kovacs; Ambrus Toth; Peter Deres; Tamas Kalai; Kálmán Hideg; Ferenc Gallyas Jr; Balazs Sumegi
Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
Anita Pálfi; Ambrus Tóth; Gyozo Kulcsár; Katalin Hantó; Peter Deres; Eva Bartha; Robert Halmosi; Eszter Szabados; Laszlo Czopf; Tamás Kálai; Kálmán Hideg; Balázs Sümegi; Kálmán Tóth
The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Deres (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Anita Palfi; Ambrus Toth; Katalin Hanto; Peter Deres; Eszter Szabados; Zoltan Szereday; Gyozo Kulcsar; Tamas Kalai; Kálmán Hideg; Ferenc Gallyas Jr; Balazs Sumegi; Kalman Toth; Robert Halmosi
PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
Journal of molecular and cellular cardiology 2006;41(1):149-59.
2006: Krisztina Kovacs; Ambrus Toth; Peter Deres; Tamas Kalai; Kálmán Hideg; Ferenc Gallyas Jr; Balazs Sumegi
Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
Biochemical pharmacology 2006;71(4):441-52.
2005: Anita Pálfi; Ambrus Tóth; Gyozo Kulcsár; Katalin Hantó; Peter Deres; Eva Bartha; Robert Halmosi; Eszter Szabados; Laszlo Czopf; Tamás Kálai; Kálmán Hideg; Balázs Sümegi; Kálmán Tóth
The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts.
The Journal of pharmacology and experimental therapeutics 2005;315(1):273-82.
2005: Arpad Boronkai; Nándor Gábor Than; Rita Magenheim; Szabolcs Bellyei; Andras Szigeti; Peter Deres; B Hargitai; Balazs Sumegi; Zoltán Papp; Janos Rigo
Extremely high maternal alkaline phosphatase serum concentration with syncytiotrophoblastic origin.
Journal of clinical pathology 2005;58(1):72-6.
2005: Peter Deres; Robert Halmosi; Ambrus Toth; Krisztina Kovacs; Anita Palfi; Tamas Habon; Laszlo Czopf; Tamas Kalai; Kálmán Hideg; Balazs Sumegi; Kalman Toth
Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound.
Journal of cardiovascular pharmacology 2005;45(1):36-43.
2004: Krisztina Kovacs; Ambrus Toth; Peter Deres; Tamas Kalai; Kálmán Hideg; Balazs Sumegi
Myocardial protection by selective poly(ADP-ribose) polymerase inhibitors.
Experimental and clinical cardiology 2004;9(1):17-20.
2003: Ambrus Toth; Krisztina Kovacs; Peter Deres; Robert Halmosi; Laszlo Czopf; Katalin Hanto; Tamas Kalai; Kálmán Hideg; Balazs Sumegi; Kalman Toth
Impact of a novel cardioprotective agent on the ischaemia-reperfusion-induced Akt kinase activation.
Biochemical pharmacology 2003;66(11):2263-72.
2003: Ambrus Toth; Robert Halmosi; Krisztina Kovacs; Peter Deres; Tamas Kalai; Kálmán Hideg; Kalman Toth; Balazs Sumegi
Akt activation induced by an antioxidant compound during ischemia-reperfusion.
Free radical biology & medicine 2003;35(9):1051-63.
2002: Robert Halmosi; Peter Deres; Ambrus Toth; Zoltan Berente; Tamas Kalai; Balazs Sumegi; Kálmán Hideg; Kalman Toth
2,2,5,5-Tetramethylpyrroline-based compounds in prevention of oxyradical-induced myocardial damage.
Journal of cardiovascular pharmacology 2002;40(6):854-67.